Molecular characterizations of carbapenem and ciprofloxacin resistance in clinical isolates of Pseudomonas putida

Journal of Infection and Chemotherapy

Volumn 15, Issue 1, 2009, Pages 6-12

  Kumita, Wakako ^a   Saito, Ryoichi ^a,b   Sato, Kenya ^a   Ode, Takashi ^a   Moriya, Kyoji ^b   Koike, Kazuhiko ^b   Chida, Toshio ^a   Okamura, Noboru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

DNA gyrase; Efflux pump; OprD; Pseudomonas putida; Topoisomerase IV

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; DORIPENEM; IMIPENEM; INTEGRASE; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; PORIN; PROTEIN PARC; PROTEIN PARE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PSEUDOMONAS PUTIDA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 62449285698     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-008-0661-9     Document Type: Article

References (22)

1. S. Ladhani Z.A. Bhutta 1998 Neonatal Pseudomonas putida infection presenting as staphylococcal scalded skin syndrome Eur J Clin Microbiol Infect Dis 17 642 644
2. R.J. Fass J. Barnishan M.C. Solomon L.W. Ayers 1996 In vitro activities of quinolones, β-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative Gram-negative bacilli Antimicrob Agents Chemother 40 1412 1418
3. G. Lombardi F. Luzzaro J.D. Docquier M.L. Riccio M. Perilli A. Coli 2002 Nosocomial infections caused by multidrug-resistant isolates of Pseudomonas putida producing VIM-1 metallo-β-lactamase J Clin Microbiol 40 4051 4055
4. J.D. Docquier M.L. Riccio C. Mugnaioli F. Luzzaro A. Endimiani A. Toniolo 2003 IMP-12, a new plasmid-encoded metallo-β-lactamase from a Pseudomonas putida clinical isolate Antimicrob Agents Chemother 47 1522 1528
5. T. Horii H. Muramatsu Y. Iinuma 2005 Mechanisms of resistance to fluoroquinolones and carbapenems in Pseudomonas putida J Antimicrob Chemother 56 643 647
6. K. Lee J.B. Lim J.H. Yum D.G. Yong Y.S. Chong J.M. Kim 2002 blaVIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital Antimicrob Agents Chemother 46 1053 1058
7. N. Shibata Y.D.K. Yamane T. Yagi H. Kurokawa K. Shibayama H. Kato 2003 PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by Gram-negative bacteria isolated in Japan, with a focus on the class 3 integron J Clin Microbiol 41 5407 5413
8. D.M. Livermore 2001 Of Pseudomonas, porins, pumps and carbapenems J Antimicrob Chemother 47 247 250
9. T. Kohler M. Michea-Hamzehpour S.F. Epp J.C. Pechere 1999 Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems Antimicrob Agents Chemother 43 424 427
10. S. Jalal B. Wretlind 1998 Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa Microb Drug Resist 4 257 261
11. R.E. Hancock 1998 Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria Clin Infect Dis 27 Suppl1 S93 S99
12. X.Z. Li H. Nikaido K. Poole 1995 Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa Antimicrob Agents Chemother 39 1948 1953
13. J.R. Aeschlimann 2003 The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other Gramnegative bacteria Pharmacotherapy 23 916 924
14. J.L. Ramos E. Duque P. Godoy A. Segura 1998 Efflux pumps involved in toluene tolerance in Pseudomonas putida DOT-T1E J Bacteriol 180 3323 3329
15. J. Kieboom J.A.M. de Bont 2001 Identification of molecular characterization of an efflux system involved in Pseudomonas putida S12 multidrug resistance Microbiology 147 43 51
16. F. Fukumori H. Hirayama H. Takami A. Inoue K. Horikoshi 1998 Isolation and transposon mutagenesis of a Pseudomonas putida KT2442 toluene-resistant variant: involvement of an efflux system in solvent tolerance Extremophiles 2 395 400
17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 15th informational supplement M100-S15. Wayne: CLSI; 2005.
18. T.E. Renau R. Leger E.M. Flamme J. Sangalang M.W. She R. Yen 1999 Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin J Med Chem 42 4928 4931
19. M. Oethinger W.V. Kern A.S. Jellen-Ritter L.M. McMurry S.B. Levy 2000 Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump Antimicrob Agents Chemother 44 10 13
20. S. Wensi 2007 Hu, Shu-Man Yao, Chang-Phone Fung, Yi-Ping Hsieh, Chang-Pan Liu, Jing-Fang Lin. An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii Antimicrob Agents Chemother 51 3844 3852
21. B.L. Ge P.F. McDermott D.G. White J.H. Meng 2005 Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli Antimicrob Agents Chemother 49 3347 3354
22. R. Saito K. Sato W. Kumita N. Inami H. Nishiyama N. Okamura 2006 Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone- resistant clinical isolates of Proteus mirabilis J Antimicrob Chemother 58 673 677